Literature DB >> 10420723

[Hepatic porphyrias and alcohol].

M O Doss1, A Kühnel, U Gross, I Sieg.   

Abstract

Alcohol has an porphyrinogenic action and can cause a disturbance of porphyrin metabolism in healthy people as well as lead to a biochemical and clinical manifestation of acute and chronic hepatic porphyrias, especially acute intermittent porphyria and porphyria cutanea tarda. After excessive consumption of alcohol a temporary, clinically asymptomatic secondary hepatic coproporphyrinuria in man can be observed, which can become persistent in cases of alcohol-induced liver damage. Nowadays alcohol-liver-porphyrinuria syndrome is the first to be mentioned in secondary hepatic disturbances of porphyrin metabolism. In people with a genetic lack of uroporphyrinogen-decarboxylase alcohol is able to transform an asymptomatic coproporphyrinuria into a chronic hepatic porphyria or porphyria cutanea tarda. From experimental and clinical studies the conclusion can be drawn that alcohol inhibits the enzymes delta-aminolevulinic-acid-dehydratase (synonym: porphobilinogen-synthase), uroporphyrinogen-decarboxylase and coproporphyrinogen-oxidase and induces delta-aminolevulinic-acid-synthase in the liver. Abstinence of alcohol is a therapeutically and prophylactically important measurement in all types of hepatic porphyrias. For clinical experience follows that in cases with chronic consumption of alcohol, fatty liver, alcohol induced hepatitis and liver cirrhosis porphyrin studies in urine should be made to notice a hepatic porphyria in the latent phase very early. When dealing with abdominal and cutaneous symptoms in clinical context with consumption of alcohol one has to exclude hepatic porphyria differential diagnostically.

Entities:  

Mesh:

Year:  1999        PMID: 10420723     DOI: 10.1007/bf03044890

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  98 in total

Review 1.  [Severe liver complications in protoporphyria].

Authors:  M Frank; M O Doss
Journal:  Internist (Berl)       Date:  1991-05       Impact factor: 0.743

Review 2.  [Hepatic porphyria].

Authors:  M O Doss
Journal:  Med Klin (Munich)       Date:  1997-12-15

3.  Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease).

Authors:  A G Freesemann; L K Bhutani; K Jacob; M O Doss
Journal:  Arch Dermatol Res       Date:  1997-04       Impact factor: 3.017

4.  Localization of the human coproporphyrinogen oxidase gene to chromosome band 3q12.

Authors:  V Cacheux; P Martasek; F Fougerousse; M H Delfau; L Druart; G Tachdjian; B Grandchamp
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

5.  Acute ethanol ingestion and haem biosynthesis in healthy subjects.

Authors:  K E McColl; G G Thompson; M R Moore; A Goldberg
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

6.  Pathobiochemical transition of secondary coproporphyrinuria to chronic hepatic porphyria in humans.

Authors:  M Doss
Journal:  Klin Wochenschr       Date:  1980-02-01

Review 7.  Alcohol-induced changes in urinary aminolevulinic acid and porphyrins: unrelated to liver disease.

Authors:  N Schoenfeld; R Mamet; L Leibovici; A Lanir
Journal:  Alcohol       Date:  1996 Jan-Feb       Impact factor: 2.405

8.  Influence of chronic alcohol consumption on hepatic heme and porphyrin metabolism.

Authors:  R Teschke; C Gorys-Könemann; T Daldrup; G Goerz
Journal:  Biochem Pharmacol       Date:  1987-04-01       Impact factor: 5.858

9.  [Liver cirrhosis in protoporphyria: bile acid therapy and liver transplantation].

Authors:  M Frank; M O Doss
Journal:  Z Gastroenterol       Date:  1995-07       Impact factor: 2.000

Review 10.  Treatment of the porphyrias.

Authors:  R Kauppinen; K Timonen; P Mustajoki
Journal:  Ann Med       Date:  1994-02       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.